GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is now emerging as a significant focus in healthcare research, largely due to its impressive impact on treating diseases such as second type diabetes and weight gain. Recent research have shown that more than glucose control, GLP-1 medications offer potential for cardiovascular well-being